8,115 Shares in Tenet Healthcare Corporation $THC Bought by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC purchased a new position in Tenet Healthcare Corporation (NYSE:THC) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 8,115 shares of the company’s stock, valued at approximately $1,648,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Chung Wu Investment Group LLC purchased a new position in Tenet Healthcare during the 2nd quarter valued at about $35,000. Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth approximately $41,000. Canada Pension Plan Investment Board bought a new position in shares of Tenet Healthcare during the second quarter valued at approximately $35,000. Caitong International Asset Management Co. Ltd lifted its stake in Tenet Healthcare by 2,227.3% in the second quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after acquiring an additional 245 shares during the period. Finally, True Wealth Design LLC increased its position in Tenet Healthcare by 238.2% during the 2nd quarter. True Wealth Design LLC now owns 257 shares of the company’s stock valued at $45,000 after purchasing an additional 181 shares during the period. 95.44% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Cantor Fitzgerald lifted their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Raymond James Financial set a $245.00 target price on Tenet Healthcare in a research note on Wednesday, October 29th. Mizuho increased their price objective on Tenet Healthcare from $194.00 to $225.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. The Goldman Sachs Group started coverage on shares of Tenet Healthcare in a report on Tuesday, October 14th. They set a “buy” rating and a $224.00 target price on the stock. Finally, KeyCorp increased their price target on shares of Tenet Healthcare from $205.00 to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and an average price target of $233.81.

Insiders Place Their Bets

In other news, Director Richard W. Fisher sold 2,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total value of $521,075.00. Following the completion of the sale, the director directly owned 8,792 shares in the company, valued at $1,832,516.56. The trade was a 22.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider R. Scott Ramsey sold 13,322 shares of the stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $205.11, for a total transaction of $2,732,475.42. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 45,500 shares of company stock valued at $9,247,071. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $196.71 on Friday. The stock has a market cap of $17.29 billion, a price-to-earnings ratio of 13.48, a PEG ratio of 0.83 and a beta of 1.41. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.64. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $222.82. The firm’s 50-day moving average is $201.55 and its 200 day moving average is $190.80.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, topping analysts’ consensus estimates of $3.33 by $0.37. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. During the same period in the previous year, the business earned $2.93 EPS. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.